- $4.12bn
- $3.75bn
- $1.19bn
- 83
- 57
- 48
- 67
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 22.79 | ||
| PEG Ratio (f) | 1.21 | ||
| EPS Growth (f) | 23.24% | ||
| Dividend Yield (f) | 5.11% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 9.34 | ||
| Price to Tang. Book | 9.34 | ||
| Price to Free Cashflow | 9.93 | ||
| Price to Sales | 3.21 | ||
| EV to EBITDA | 17.45 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 14.8% | ||
| Return on Equity | 42.11% | ||
| Operating Margin | 15.9% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 943.28 | 1,540.61 | 985.3 | 854.75 | 1,194.55 | 1,285.01 | 1,528.83 | 9.86% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +55.56 | +81.21 | -59.94 | n/a | n/a | +16.76 | +35.17 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Moelis & Company is a global independent investment bank that provides strategic advice and solutions to a diverse client base, including corporations, governments and financial sponsors. The Company assists its clients in achieving their strategic goals by offering comprehensive integrated financial advisory services across various industry sectors. It advises clients on their critical decisions, including mergers and acquisitions (M&A), recapitalizations and restructurings, capital markets transactions, private fund raisings and secondary transactions and other corporate finance matters. It has an M&A and strategic advisory franchise advising clients on mergers, acquisitions and divestitures, spin-offs, joint ventures, fairness opinions and shareholder advisory across all sectors. For its clients seeking capital market solutions, it also structures and executes customized financing solutions and advises clients on all aspects of public and private equity and debt transactions.
Directors
- Kenneth Moelis CHM (62)
- Navid Mahmoodzadegan CPR (52)
- Jeffrey Raich CPR (54)
- Eric Cantor VCH (57)
- Joseph Simon CFO (62)
- Elizabeth Crain COO (56)
- Osamu Watanabe GCN (60)
- Melissa Mariaschin MDR
- John Allison IND (72)
- Yolonda Richardson IND (59)
- Kenneth Shropshire IND (66)
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- January 9th, 2014
- Public Since
- April 16th, 2014
- No. of Shareholders
- 80
- No. of Employees
- 1,308
- Sector
- Investment Banking & Investment Services
- Industry
- Financials
- Exchange
New York Stock Exchange- Shares in Issue
- 78,507,847
- Address
- 399 Park Avenue, 5Th Floor, NEW YORK, 10022
- Web
- https://www.moelis.com/
- Phone
- +1 2128833800
- Auditors
- Deloitte & Touche LLP
Latest News for MC
Upcoming Events for MC
Dividend For MC.N - 0.6500 USD
Moelis & Co Annual Shareholders Meeting
Moelis & Co Annual Shareholders Meeting
Q2 2025 Moelis & Co Earnings Release
Q3 2025 Moelis & Co Earnings Release
Similar to MC
Acadian Asset Management
New York Stock Exchange
Affiliated Managers
New York Stock Exchange
Alliancebernstein Holding LP
New York Stock Exchange
Ameriprise Financial
New York Stock Exchange
AMTD IDEA
New York Stock Exchange
FAQ
As of Today at 22:06 UTC, shares in Moelis & Co are trading at $52.53. This share price information is delayed by 15 minutes.
Shares in Moelis & Co last closed at $52.53 and the price had moved by +4.52% over the past 365 days. In terms of relative price strength the Moelis & Co share price has underperformed the S&P500 Index by -3.53% over the past year.
The overall consensus recommendation for Moelis & Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Moelis & Co dividend yield is 5.81% based on the trailing twelve month period.
Last year, Moelis & Co paid a total dividend of $3.05, and it currently has a trailing dividend yield of 5.81%.Looking ahead, shares in Moelis & Co are due to go ex-dividend on 2025-05-05 and the next dividend pay date is 2025-06-20.
Moelis & Co are due to go ex-dividend on 2025-05-05 and the next dividend pay date is 2025-06-20. The historic dividend yield on Moelis & Co shares is currently 5.81%.
To buy shares in Moelis & Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $52.53, shares in Moelis & Co had a market capitalisation of $4.12bn.
Here are the trading details for Moelis & Co:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: MC
Based on an overall assessment of its quality, value and momentum Moelis & Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Moelis & Co is $50.67. That is 3.54% below the last closing price of $52.53.
Analysts covering Moelis & Co currently have a consensus Earnings Per Share (EPS) forecast of $2.07 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Moelis & Co. Over the past six months, its share price has underperformed the S&P500 Index by -15.97%.
As of the last closing price of $52.53, shares in Moelis & Co were trading -22.69% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Moelis & Co PE ratio based on its reported earnings over the past 12 months is 22.79. The shares last closed at $52.53.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Moelis & Co's management team is headed by:
- Kenneth Moelis - CHM
- Navid Mahmoodzadegan - CPR
- Jeffrey Raich - CPR
- Eric Cantor - VCH
- Joseph Simon - CFO
- Elizabeth Crain - COO
- Osamu Watanabe - GCN
- Melissa Mariaschin - MDR
- John Allison - IND
- Yolonda Richardson - IND
- Kenneth Shropshire - IND